Skip to content

Drug interactions

Umeclidinium bromide / vilanterol inhaled + Ziprasidone

Severity: Moderate

Umeclidinium bromide / vilanterol inhaled and Ziprasidone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vilanterol, a long-acting beta-agonist, can cause QT prolongation and tachycardia at high exposure, and ziprasidone prolongs the QT interval. The clinical risk from the inhaled dose is modest, but it may add to arrhythmia risk in susceptible patients.

What this interaction means in plain words

Umeclidinium bromide / vilanterol inhaled and Ziprasidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT effects from beta-2 agonist-related hypokalemia and ziprasidone hERG blockade.

What to do

Use the inhaler at the recommended dose without extra doses, and monitor heart rhythm and potassium in patients with cardiac risk factors. Obtain an ECG if palpitations or syncope occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Umeclidinium bromide / vilanterol inhaled and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Umeclidinium bromide / vilanterol inhaled with Ziprasidone?

MediHelp rates the interaction as moderate. Umeclidinium bromide / vilanterol inhaled and Ziprasidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Vilanterol, a long-acting beta-agonist, can cause QT prolongation and tachycardia at high exposure, and ziprasidone prolongs the QT interval. The clinical risk from the inhaled dose is modest, but it may add to arrhythmia risk in susceptible patients.

How serious is the interaction between Umeclidinium bromide / vilanterol inhaled and Ziprasidone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the inhaler at the recommended dose without extra doses, and monitor heart rhythm and potassium in patients with cardiac risk factors. Obtain an ECG if palpitations or syncope occur.

What other medicines interact with Ziprasidone?

MediHelp also lists interactions of Ziprasidone with, for example, Amiodarone, Amitriptyline, Arsenic trioxide. The full list is on the Ziprasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in